The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group - PubMed (original) (raw)
Affiliations
- PMID: 7769501
Clinical Trial
The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group
F M Sacks et al. J Hypertens Suppl. 1994.
Abstract
Objective: To study the effects of moderate doses of fish oil on blood pressure and high-density lipoprotein (HDL)-cholesterol.
Methods: The participants were 350 normotensive men and women aged 30-54 years who were enrolled from seven academic medical centers in phase I of the Trials of Hypertension Prevention. They were randomly assigned to receive placebo or 6 g purified fish oil once a day, which supplied 3 g n-3 polyunsaturated fatty acids for 6 months.
Results: Baseline blood pressure was (mean +/- SD) 123 +/- 9/81 +/- 5 mmHg. The mean differences in the blood pressure changes between the fish oil and placebo groups were not statistically significant. There was no tendency for fish oil to reduce blood pressure more in subjects with baseline blood pressures in the upper versus the lower quartile (132/87 versus 114/75 mmHg), low habitual fish consumption (0.4 versus 2.9 times a week) or low baseline plasma levels of n-3 fatty acids. Fish oil increased HDL2-cholesterol significantly compared with the placebo group. Subgroup analysis showed this effect to be significant in the women but not in the men. Increases in serum phospholipid n-3 fatty acids were significantly correlated with increases in HDL2-cholesterol and decreases in systolic blood pressure.
Conclusion: Moderate amounts of fish oil (6 g/day) are unlikely to lower blood pressure in normotensive persons, but may increase HDL2-cholesterol, particularly in women.
Similar articles
- Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention.
Sacks FM, Hebert P, Appel LJ, Borhani NO, Applegate WB, Cohen JD, Cutler JA, Kirchner KA, Kuller LH, Roth KJ, et al. Sacks FM, et al. J Hypertens. 1994 Feb;12(2):209-13. J Hypertens. 1994. PMID: 8021472 Clinical Trial. - Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
Bairati I, Roy L, Meyer F. Bairati I, et al. Can J Cardiol. 1992 Jan-Feb;8(1):41-6. Can J Cardiol. 1992. PMID: 1617510 Clinical Trial. - Fish oil as an adjuvant in the treatment of hypertension.
Gray DR, Gozzip CG, Eastham JH, Kashyap ML. Gray DR, et al. Pharmacotherapy. 1996 Mar-Apr;16(2):295-300. Pharmacotherapy. 1996. PMID: 8820475 Clinical Trial. - [Hemodynamic effect of unsaturated fatty acids. Do fish oils have an antihypertensive effect?].
Düsing R. Düsing R. Fortschr Med. 1989 Nov 20;107(33):701-4. Fortschr Med. 1989. PMID: 2689317 Review. German. - The biological actions and potential clinical significance of dietary omega-3 fatty acids.
Gorlin R. Gorlin R. Arch Intern Med. 1988 Sep;148(9):2043-8. Arch Intern Med. 1988. PMID: 3046544 Review.
Cited by
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2020 Feb 29;3(3):CD003177. doi: 10.1002/14651858.CD003177.pub5. Cochrane Database Syst Rev. 2020. PMID: 32114706 Free PMC article. - Effect of sesame oil on diuretics or Beta-blockers in the modulation of blood pressure, anthropometry, lipid profile, and redox status.
Sankar D, Rao MR, Sambandam G, Pugalendi KV. Sankar D, et al. Yale J Biol Med. 2006 Mar;79(1):19-26. Yale J Biol Med. 2006. PMID: 17876372 Free PMC article. Clinical Trial. - Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2018 Nov 30;11(11):CD003177. doi: 10.1002/14651858.CD003177.pub4. Cochrane Database Syst Rev. 2018. PMID: 30521670 Free PMC article. Updated. - Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD003177. doi: 10.1002/14651858.CD003177.pub3. Cochrane Database Syst Rev. 2018. PMID: 30019766 Free PMC article. Updated. Review. - Omega 3 fatty acids for prevention and treatment of cardiovascular disease.
Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE, Davey Smith G, Riemersma RA, Ebrahim SB. Hooper L, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003177. doi: 10.1002/14651858.CD003177.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495044 Free PMC article. Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical